Category: Finance
ASX Small Caps Lunch Wrap: Who reckons the world is finally ready for ‘roid-friendly sports?
Local markets have recovered from yesterday’s beating, bouncing back with all the vim, vigour and zest you’d expect, considering the mood the ASX has been [more…]
Resources Top 5: Uranium Edition
ASX uranium stocks surge as spot price hits 17-year high Led in early trade by near term miner Deep Yellow (ASX:DYL), enrichment hopeful Global Uranium [more…]
Oversubscribed $13m placement places Conrad Asia Energy on the fast track towards gas production
Institutional and sophisticated investors have oversubscribed for a $13m placement and an SPP which could deliver another $2m from retail investors Proceeds ensure Conrad Asia [more…]
Austral regroups to accelerate copper haulage from Anthill
Austral Resources signs new haulage contract with REGROUP for its Anthill copper mine Addition of five new trucks expected to help address road haulage shortfall [more…]
Ground Breakers: Uranium lovers pile in on spot madness and Glencore keeps Murrin Murrin humming for now
Kazatomprom confirms production issues, putting a rocket up spot uranium market Aussie players BOE, PDN, BMN, DYL, PEN and LOT among those rising this morning [more…]
‘It all adds up to a drink you just want to smash’? Take my money.
Rose is the wild child of wine: a style without a rule book, where winemakers choose whatever grape variety they like to craft their blends. [more…]
Chariot double dips at Black Mountain with lithium and base metals success
Chariot Corporation reports strong results in first three holes drilled into its Black Mountain lithium project in Wyoming Assays include individual lithium and tantalum grades [more…]
ASX Health Stocks: Althea strikes deal in Canada, will make 40pc of all cannabis-infused drinks in the country
Althea strikes manufacturing deal in Canada It’s a three-ear deal to produce 700,000 units p/a with sales value of CAD$6.5 million Company said it will [more…]
Morgan Stanley name drops ASX-listed Ebos as likely to fatten-up on Asia’s Ozempic weight-loss craze
Celebrating 100 years of making drugs in Denmark this week, the fat-blasting Novo Nordisk dropped some more really big numbers this week, driven by monstrous [more…]
ASX Quarterly Wrap: A robust scoping study in Argentina and Mark Creasy increases his holding in PGD
It’s quarterly season again as the ASX market announcements page becomes increasingly flooded with update lodgements. To save you the trouble of trudging through it [more…]
